The first-ever vaccine protecting babies from RSV, a respiratory virus that can cause severe symptoms among young children, is now up for federal approval, the manufacturer Pfizer said Tuesday.The U.S. Food and Drug Administration is expected to make a decision this August after agreeing to review Pfizer's maternal vaccine, which would be administered to pregnant patients in order to immunize their fetuses before birth, according to the announcement.
#people #announcement #young-children #hospitalizations #high-levels #older-adults #global-health #infectious-disease
[
add
]
[
|
|
...
]